Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

News und Analysen

Why Shares of Western Alliance, PacWest Bancorp, and KeyCorp Are Rising Today: https://g.foolcdn.com/editorial/images/732859/generic-upward-16.jpg
Why Shares of Western Alliance, PacWest Bancorp, and KeyCorp Are Rising Today

Shares of bank stocks are rallying today after Western Alliance Bancorporation (NYSE: WAL) issued a positive update on its deposit trends this morning.

Shares of Western Alliance traded more than

Ready to Buy the Dip? This Biotech Stock Is a Smart Buy: https://g.foolcdn.com/editorial/images/732376/vaccine-covid-coronavirus-pandemic-health.jpg
Ready to Buy the Dip? This Biotech Stock Is a Smart Buy

Moderna (NASDAQ: MRNA) saw its shares jump in 2021 and 2022 on the back of strong sales of its COVID-19 vaccine Spikevax. Now that those sales are slumping, the biotech company's shares have fallen

EQS-News: KION Group CEO Rob Smith: 'We are following a clear roadmap to grow profitably and look to the future with confidence.': http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23724/Kion_Group_logo.svg.png
EQS-News: KION Group CEO Rob Smith: 'We are following a clear roadmap to grow profitably and look to the future with confidence.'
EQS-News: KION Group CEO Rob Smith: 'We are following a clear roadmap to grow profitably and look to the future with confidence.'
EQS-News: Annual General Meeting of Telefónica Deutschland resolves dividend of EUR 0.18 per share for the financial year 2022: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24073/Telefonica_Logo.svg.png
EQS-News: Annual General Meeting of Telefónica Deutschland resolves dividend of EUR 0.18 per share for the financial year 2022
EQS-News: Annual General Meeting of Telefónica Deutschland resolves dividend of EUR 0.18 per share for the financial year 2022
EQS-News: Annual General Meeting of Telefónica Deutschland resolves dividend of EUR 0.18 per share for the financial year 2022: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24073/Telefonica_Logo.svg.png
EQS-News: Annual General Meeting of Telefónica Deutschland resolves dividend of EUR 0.18 per share for the financial year 2022
EQS-News: Annual General Meeting of Telefónica Deutschland resolves dividend of EUR 0.18 per share for the financial year 2022
EQS-News: freenet AG: Annual General Meeting resolves dividend of EUR 1.68 per share (previous year: EUR 1.57): http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24058/375px-Freenet_AG_Logo.svg.png
EQS-News: freenet AG: Annual General Meeting resolves dividend of EUR 1.68 per share (previous year: EUR 1.57)
EQS-News: freenet AG: Annual General Meeting resolves dividend of EUR 1.68 per share (previous year: EUR 1.57)
EQS-News: freenet AG: Annual General Meeting resolves dividend of EUR 1.68 per share (previous year: EUR 1.57): http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24058/375px-Freenet_AG_Logo.svg.png
EQS-News: freenet AG: Annual General Meeting resolves dividend of EUR 1.68 per share (previous year: EUR 1.57)
EQS-News: freenet AG: Annual General Meeting resolves dividend of EUR 1.68 per share (previous year: EUR 1.57)
Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc: https://mms.businesswire.com/media/20210505005534/en/876086/5/5009664_Horizon_Logo_Full-Color_CMYK_M01_%281%29.jpg
Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc
Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc
If I Could Only Buy 1 Stock Right Now, This Would Be It: https://g.foolcdn.com/editorial/images/732572/a-dog-looking-out-a-car-window.jpeg
If I Could Only Buy 1 Stock Right Now, This Would Be It

The pandemic hit the travel industry hard. However, as global travel demand returns to normal, vacation rental leader Airbnb (NASDAQ: ABNB) has demonstrated its resilience. 

Surprisingly even now

Commerzbank with strong start to the year – net profit almost doubled: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23454/Commerzbank_%282009%29.svg.png
Commerzbank with strong start to the year – net profit almost doubled
Commerzbank with strong start to the year – net profit almost doubled
EQS-News: Commerzbank with strong start to the year – net profit almost doubled: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23454/Commerzbank_%282009%29.svg.png
EQS-News: Commerzbank with strong start to the year – net profit almost doubled
EQS-News: Commerzbank with strong start to the year – net profit almost doubled
PulteGroup Names Industry Veteran Matthew Koart as Chief Operating Officer: https://mms.businesswire.com/media/20230516005820/en/1795305/5/Matthew_Koart.jpg
PulteGroup Names Industry Veteran Matthew Koart as Chief Operating Officer


PulteGroup, Inc. (NYSE: PHM) announced today that experienced industry veteran Matthew Koart has been named as Executive Vice President and Chief Operating Officer. Koart replaces John Chadwick who

Why AST SpaceMobile Stock Is Up Today: https://g.foolcdn.com/editorial/images/732770/earth-planet-and-satellite-view-from-space-getty.jpg
Why AST SpaceMobile Stock Is Up Today

Space-based telecom company AST SpaceMobile (NASDAQ: ASTS) reported progress in commercializing its tech during its most recent quarter. That has investors excited about what is to come, sending

Could Latecomer Moderna Match Big Pharma Rivals in RSV?: https://g.foolcdn.com/editorial/images/732515/gettyimages-man-gets-a-vaccine.jpg
Could Latecomer Moderna Match Big Pharma Rivals in RSV?

Moderna (NASDAQ: MRNA) started its billion-dollar story with the coronavirus vaccine. But the next chapter could revolve around another respiratory vaccine: one for respiratory syncytial virus

Better Growth Stock: Tilray vs. Green Thumb Industries: https://g.foolcdn.com/editorial/images/732448/money.jpeg
Better Growth Stock: Tilray vs. Green Thumb Industries

Investing in the cannabis industry is tricky. Some investors may be tempted to entirely shun the space based on its performance over the last two years. However, a few companies still offer

EQS-News: Jens Rönnberg elected new Chairman of the Supervisory Board of GRENKE AG: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24105/Grenke_Logo.jpg
EQS-News: Jens Rönnberg elected new Chairman of the Supervisory Board of GRENKE AG
EQS-News: Jens Rönnberg elected new Chairman of the Supervisory Board of GRENKE AG
EQS-News: GRENKE AG: GRENKE AG’s ordinary Annual General Meeting 2023 approves all agenda items and appoints new Supervisory Board members: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24105/Grenke_Logo.jpg
EQS-News: GRENKE AG: GRENKE AG’s ordinary Annual General Meeting 2023 approves all agenda items and appoints new Supervisory Board members
EQS-News: GRENKE AG: GRENKE AG’s ordinary Annual General Meeting 2023 approves all agenda items and appoints new Supervisory Board members
Roku: Is It Worth Buying the Dip?: https://g.foolcdn.com/editorial/images/732032/gettyimages-1345487755.jpg
Roku: Is It Worth Buying the Dip?

Roku (NASDAQ: ROKU) recently reported its first-quarter 2023 quarterly results. Unfortunately, investors were disappointed that its outlook for the second quarter of 2023 projects only 1%

Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc: https://mms.businesswire.com/media/20210505005534/en/876086/5/5009664_Horizon_Logo_Full-Color_CMYK_M01_%281%29.jpg
Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc
Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc
Why MongoDB Stock Raced Nearly 5% Higher Today: https://g.foolcdn.com/editorial/images/732630/person-gazing-at-a-laptop-located-on-a-desk-already-supporting-two-pc-monitors.jpg
Why MongoDB Stock Raced Nearly 5% Higher Today

Next-generation database specialist MongoDB (NASDAQ: MDB) was an outlier stock on Monday. The company's shares rose by just under 5% on the day, thanks in no small part to a price target raise from

Why Emergent BioSolutions Stock Inched Slightly Higher Today: https://g.foolcdn.com/editorial/images/732629/medical-professional-working-at-a-computer-terminal.jpg
Why Emergent BioSolutions Stock Inched Slightly Higher Today

Emergent BioSolutions (NYSE: EBS) has been quite the up-and-down stock of late. On Monday, it had an up session on the market, creeping northward by 1.2% and exceeding the S&P 500's gain of 0.3%

Acadia Healthcare Names Judith Scimone Company’s New Chief Human Resources Officer: https://mms.businesswire.com/media/20230512005391/en/1792611/5/Judith_Scimone_Headshot_1.jpg
Acadia Healthcare Names Judith Scimone Company’s New Chief Human Resources Officer


Acadia Healthcare Company Inc. (NASDAQ: ACHC) today announced that Judith Scimone has joined Acadia as the Company’s Chief Human Resources Officer (CHRO). In this role, she will shape and advance

Is MercadoLibre Stock a Buy Now?: https://g.foolcdn.com/editorial/images/732246/young-woman-holding-credit-card-and-smartphone-and-thinking-with-chin-on-fist-online-mobile-shopping-e-commerce.jpg
Is MercadoLibre Stock a Buy Now?

In 2020, the pandemic's onset proved a huge boon for e-commerce platforms as people turned to online shopping for their everyday needs. Sales surged through the roof in the next two years for these

Here's How Jamie Dimon Thinks Regulators Should Address the Banking Crisis: https://g.foolcdn.com/editorial/images/732273/screen-shot-2023-05-12-at-11254-pm.png
Here's How Jamie Dimon Thinks Regulators Should Address the Banking Crisis

Four banks in the U.S. have now collapsed since March, and while it looks like much of the banking system has avoided broader contagion, the banking crisis is certainly not over just yet. Recently

Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc: https://mms.businesswire.com/media/20210505005534/en/876086/5/5009664_Horizon_Logo_Full-Color_CMYK_M01_%281%29.jpg
Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc
Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc